Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

Summary

The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

Timeline

Start

2021-01-26

Primary completion

2024-01-02

Completion

2024-02-22

Outcome

Met primary endpoint

release “Ironwood previously reported that the STARS clinical trial met its primary endpoint” ironwoodpharma.com ↗

Drugs

Indications